Medical Developments International Limited
MDDVF
$0.37
$0.0721.99%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.47% | 9.16% | 16.33% | 14.49% | 12.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.47% | 9.16% | 16.33% | 14.49% | 12.41% |
| Cost of Revenue | -0.95% | 2.63% | 8.41% | 2.45% | -2.99% |
| Gross Profit | 6.40% | 11.50% | 19.18% | 19.27% | 19.13% |
| SG&A Expenses | 2.17% | -13.43% | -24.47% | -31.74% | -37.78% |
| Depreciation & Amortization | -16.27% | -12.23% | -6.88% | 2.48% | 12.56% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.20% | -9.88% | -17.09% | -23.30% | -28.66% |
| Operating Income | 87.95% | 94.75% | 95.78% | 92.79% | 90.93% |
| Income Before Tax | 98.13% | 99.62% | 100.53% | 65.29% | 17.37% |
| Income Tax Expenses | -99.44% | -99.29% | -99.11% | 189.19% | 313.54% |
| Earnings from Continuing Operations | 98.56% | 99.53% | 100.25% | 50.66% | -53.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 98.56% | 99.53% | 100.25% | 50.66% | -53.73% |
| EBIT | 87.95% | 94.75% | 95.78% | 92.79% | 90.93% |
| EBITDA | 859.38% | 130.54% | 115.23% | 105.41% | 98.69% |
| EPS Basic | 98.86% | 99.63% | 100.19% | 50.50% | -54.17% |
| Normalized Basic EPS | 91.67% | 99.16% | 100.76% | 91.72% | 85.74% |
| EPS Diluted | 98.86% | 99.63% | 100.19% | 50.50% | -54.07% |
| Normalized Diluted EPS | 91.67% | 99.16% | 100.76% | 91.72% | 85.74% |
| Average Basic Shares Outstanding | 16.32% | 21.56% | 27.45% | 19.84% | 12.22% |
| Average Diluted Shares Outstanding | 13.27% | 21.26% | 30.46% | 22.85% | 15.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |